Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2022-04-11 Regulatory Filings
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1914 characters) and contains the header 'RNS Number : 0143I' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, brief operational announcement related to trading mechanics, not a comprehensive financial report or a standard regulatory filing like 10-K or ER. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIV, DIRS, or ER), the most appropriate fallback category is Regulatory Filings (RNS). The 'MENU VS MEAL' rule suggests that short announcements about market operations should be classified as RNS if they don't fit elsewhere.
2022-04-11 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1931 characters) and contains the header 'RNS Number : 9987H' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, short-form regulatory market announcement related to trading halts or price volatility. This type of brief, market-specific notification that does not contain comprehensive financial statements or management discussion fits best under the general 'Regulatory Filings' category, as it is a direct communication to the market via the RNS system, rather than a specific report type like 10-K, ER, or IR. It is not an announcement of a report publication (RPA), but a direct regulatory update.
2022-04-11 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security's auction call, which is a specific, non-financial regulatory market announcement. Since this is a general regulatory announcement that doesn't fit the specific categories like DIV, DIRS, or ER, it falls best under the general regulatory filing category.
2022-04-11 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details the 'Issue of Equity and Total Voting Rights' following option exercises, which is a mandatory disclosure related to share capital changes. This type of announcement, disseminated via the Regulatory News Service (RNS), fits best under the general 'Regulatory Filings' category (RNS) or potentially 'Share Issue/Capital Change' (SHA). Since the primary function of this document is the official regulatory dissemination via RNS, and it is a short announcement rather than a comprehensive report, RNS is the most appropriate classification, although SHA is also highly relevant. Given the context of RNS being the distribution mechanism and the content being a specific corporate action announcement, RNS serves as the appropriate general regulatory filing code for this type of market notice.
2022-04-08 English
AffyXell partners with Biocytogen and KNTSC
M&A Activity Classification · 99% confidence The document begins with 'RNS Number' and is dated '08 April 2022'. It announces a collaboration agreement between Avacta Group plc's joint venture, AffyXell, with Biocytogen and KNTSC regarding drug development and testing. This is a typical corporate announcement disseminated through the Regulatory News Service (RNS) system of the London Stock Exchange. Since it is a specific, material business update that doesn't fit the definitions for ER, CT, DIV, or DIRS, and it is clearly an announcement rather than a full report (like 10-K or IR), the most appropriate classification is the general regulatory announcement category, RNS, as it is explicitly sourced from RNS and contains general corporate news.
2022-04-08 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change Classification · 99% confidence The document begins with 'RNS Number : 7022H' and is dated April 7, 2022. The content explicitly announces the 'Issue of Equity and Total Voting Rights' following an employee's exercise of share options, detailing the number of new shares issued and the resulting enlarged issued share capital. This is a standard regulatory announcement concerning share capital changes. While it relates to share capital, the specific action described (issuance due to option exercise impacting total shares) fits best under 'Share Issue/Capital Change' (SHA). It is not a general regulatory filing (RNS) because it fits a more specific category, and it is not a financing update (CAP) which usually implies fundraising or debt issuance. The document is a direct announcement of the change, not a notice about the publication of a report.
2022-04-07 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.